Sign In
Buy ALIM
$5.54
+0 (+0%)
At Close: Dec 12, 2024
New Strong Sell Stocks for April 26th
11:24am, Tuesday, 26'th Apr 2022 Zacks Investment Research
ANIK, ALIM, and ADAP have been added to the Zacks Rank #5 (Strong Sell) List on April 26, 2022
New Strong Sell Stocks for April 26th
09:02am, Tuesday, 26'th Apr 2022
ANIK, ALIM, and ADAP have been added to the Zacks Rank #5 (Strong Sell) List on April 26, 2022
Trevena (TRVN) Reports Q4 Loss, Lags Revenue Estimates
12:15pm, Thursday, 31'st Mar 2022 Zacks Investment Research
Trevena (TRVN) delivered earnings and revenue surprises of 11.11% and 100.15%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for March 30th
09:44am, Wednesday, 30'th Mar 2022 Zacks Investment Research
ALIM, APPF, and CNNE have been added to the Zacks Rank #5 (Strong Sell) List on March 30, 2022.
New Strong Sell Stocks for March 30th
06:47am, Wednesday, 30'th Mar 2022
ALIM, APPF, and CNNE have been added to the Zacks Rank #5 (Strong Sell) List on March 30, 2022.
New Strong Sell Stocks for March 28th
02:48pm, Monday, 28'th Mar 2022 Zacks Investment Research
ALIM, ANIK, and APPF have been added to the Zacks Rank #5 (Strong Sell) List on March 28, 2022
New Strong Sell Stocks for March 28th
12:03pm, Monday, 28'th Mar 2022
ALIM, ANIK, and APPF have been added to the Zacks Rank #5 (Strong Sell) List on March 28, 2022
New Strong Sell Stocks for March 1st
01:35pm, Tuesday, 01'st Mar 2022 Zacks Investment Research
AGIO, ALIM, and BV have been added to the Zacks Rank #5 (Strong Sell) List on March 1, 2022
New Strong Sell Stocks for March 1st
09:58am, Tuesday, 01'st Mar 2022
AGIO, ALIM, and BV have been added to the Zacks Rank #5 (Strong Sell) List on March 1, 2022
Alimera Sciences, Inc (ALIM) CEO Richard Eiswirth on Q4 2021 Results - Earnings Call Transcript
04:59pm, Thursday, 24'th Feb 2022 Seeking Alpha
Alimera Sciences GAAP EPS of -$0.59 misses by $0.17, revenue of $13.95M beats by $0.55M
01:05pm, Thursday, 24'th Feb 2022 Seeking Alpha
Alimera Sciences press release (ALIM): Q4 GAAP EPS of -$0.59 misses by $0.17.Revenue of $13.95M (+1.3% Y/Y) beats by $0.55M.
Alimera Sciences Reports Fourth Quarter and FY 2021 Results
01:00pm, Thursday, 24'th Feb 2022 GlobeNewswire
Fourth Quarter Highlights:
Alimera Sciences, Inc (ALIM) CEO Richard Eiswirth on Q4 2021 Results - Earnings Call Transcript
11:59am, Thursday, 24'th Feb 2022
Alimera Sciences, Inc (ALIM) CEO Richard Eiswirth on Q4 2021 Results - Earnings Call Transcript
Alimera Sciences Q4 2021 Earnings Preview (NASDAQ:ALIM)
04:11pm, Wednesday, 23'rd Feb 2022 Seeking Alpha
Alimera Sciences (NASDAQ:ALIM) is scheduled to announce Q4 earnings results on Thursday, February 24th, before market open.The consensus EPS Estimate is -$0.28 and the consensus
Alimera''s 3-year data for ILUVIEN shows benefit in diabetic macular edema
02:48pm, Wednesday, 23'rd Feb 2022 Seeking Alpha
Alimera Sciences (ALIM) reported three-year results of a study, called PALADIN, of the ILUVIEN implant in patients with diabetic macular edema ((DME)), an eye complication in people
